TRIM33 and neoplasm: A recent study demonstrated an increased number of genetic alterations in TIF1 genes of tumors from paraneoplastic anti-TIF1-γ-positive patients, as well as a high expression of TIF1g in the tumor, muscle and skin of these patients.